Oregon philanthropist Hallie Ford gave a gift of $8 million to Oregon State University’s College of Health and Human Sciences
On Jun. 20, 2007, Hallie Ford, a noted Oregon philanthropist, made a gift of $8 million to Oregon…
On Jun. 20, 2007, Hallie Ford, a noted Oregon philanthropist, made a gift of $8 million to Oregon…
On May 21, 2007, Oregon Health & Science University (OHSU) announced that Grover Bagby, M.D., after 15 years…
On Mar. 20, 2007, the National Institute on Alcohol Abuse and Alcoholism (NIAAA) announced a five-year, $24 million…
On Feb. 8, 2007, Oregon Health & Science University (OHSU) and the OHSU Foundation announced the largest outright gift…
In 2007, The Oregon Translational Research and Drug Discovery Institute (OTRADI) at Oregon State University was established by…
On Oct. 19, 2006, the U.S. Food and Drug Administration (FDA) granted Glivec® (imatinib) has received US regulatory…
In 2006, The OHSU Peter O. Kohler Pavilion opened as state-of-the-art patient care facility on Marquam Hill in…
On Nov. 1, 2004, an Oregon Health & Science University (OHSU) research team announced that it was one…
On Sept. 29, 2004, a team from scientists from the Pacific Northwest National Laboratory and Oregon Health &…
On Sept. 22, 2004, the National Institutes of Health (NIH) opened the Mark O. Hatfield Clinical Research Center,…
On Sept. 14, 2004, Pacific Northwest National Laboratory (PNNL) announced it had received a $10.3 million biodefense contract…
On Jun. 16, 2004, Portland’s Schnitzer Investment Corp. donated nearly 20 acres of land at the South Willamette…
On May 25, 2004, researchers at the Vaccine and Gene Therapy Institute (VGTI) and the Oregon National Primate…
On Jan. 29, 2004, researchers at Oregon Health & Science University (OHSU) School of Medicine’s Casey Eye Institute…
On Oct. 21, 2003, scientists at Oregon Health Sciences University’s (OHSU) Casey Eye Institute announced they had found…
On Sept. 22, 2003 the Oregon Investment Fund was created with HB 3613 passage in the Oregon State…
On Aug. 17, 2003, Oregon Health & Science University (OHSU) announced the final results of a smallpox vaccine…
On Jul. 10, 2003, the University Fertility Consultants at Oregon Health & Science University (OHSU) announced they had…
On Jul. 2, 2003, Invitrogen bought Molecular Probes for $325 million in cash. The company became part of…
On Oct. 10, 2002, the Oregon Opportunity arrived as Oregon Health & Science University (OHSU) broke ground for…
On Feb. 1, 2002, the U.S. Food and Drug Administration (FDA) approved the drug Gleevec, formerly known as…
On Jul. 1, 2001, Governor John Kitzhaber signed legislation that expanded Oregon Health & Science University’s (OHSU) mission…
On May 10, 2001, the U.S. Food and Drug Administration (FDA) approved Gleevec, the world’s first targeted cancer…
On Jan. 11, 2001, Oregon Health Sciences University (OHSU) researchers reported the production of the world’s first genetically…
In 2001, the drug imatinib mesylate (Gleevec) was shown in a clinical trial to be effective against chronic…
In 2001, the Oregon Health & Science University (OHSU) Vaccine and Gene Therapy Institute and Neurological Sciences Institute…
In 2001, Oregon Health Sciences Center’s name changed to Oregon Health & Science University (OHSU) as Governor John…
On Apr. 10, 2000, the Oregon Health Science Centers (OHSU) Center for Research on Occupational and Environmental Toxicology…
In 1998, Doernbecher Children’s Hospital’s new state-of-the-art pediatric medical complex was opened. Built with private funding and bond…
In 1998, The Mark O. Hatfield Research Center was dedicated. The center houses a variety of basic and…